Scendia Biologics, LLC – Trademark Portfolio
Entity Type: 16
Scendia Biologics, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BIFORM, ALLOCYTE, and ALLOCYTE ADVANCED CELLULAR BONE MATRIX. The owner is based in Orlando, FL.
1405 South Orange Avenue, Suite 315
Orlando, FL 32806
Showing of trademarks Trademarks
Trademark Classifications
Scendia Biologics, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Scendia Biologics, LLC have?
Scendia Biologics, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does Scendia Biologics, LLC file in?
Scendia Biologics, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Scendia Biologics, LLC's most well-known trademarks?
Scendia Biologics, LLC's registered trademark portfolio includes well-known marks such as BIFORM, ALLOCYTE, and ALLOCYTE ADVANCED CELLULAR BONE MATRIX. These are among 3 currently registered trademarks in the portfolio.
What is Scendia Biologics, LLC's trademark registration success rate?
Scendia Biologics, LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.